Mindy Thompson, NP
Family · Landrum, SCNPI 1538540745
Payments from drug & device makers
Across 356 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$969
- Novo Nordisk$409
- Amgen$360
- GSK$348
- AstraZeneca$345
- Astellas Pharma US Inc$315
- plus $3K from 30 others
What the payments were for
- Food & beverage$5,687100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $969 |
| Novo Nordisk | 27 | $409 |
| Amgen | 21 | $360 |
| GSK | 21 | $348 |
| AstraZeneca(2 entities) | 23 | $345 |
| Astellas Pharma US Inc | 15 | $315 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $285 |
| Merck | 15 | $253 |
| Lilly USA, LLC | 17 | $253 |
| Pfizer | 15 | $250 |
| Eisai Inc. | 14 | $230 |
| Novartis | 13 | $225 |
| Johnson & Johnson | 16 | $186 |
| Boehringer Ingelheim | 11 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $167 |
| Exact Sciences | 7 | $109 |
| Esperion Therapeutics, Inc. | 5 | $97 |
| Amarin Pharma, Inc. | 6 | $83 |
| Sanofi-aventis U.S. LLC | 4 | $68 |
| Edwards Lifesciences | 2 | $66 |
| Bayer | 4 | $63 |
| Biohaven Pharmaceuticals, Inc. | 3 | $60 |
| Abbott | 3 | $56 |
| Boston Scientific | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Medtronic | 1 | $24 |
| Inari Medical, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| Corium, LLC | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Dentsply Sirona Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $11 |
How this compares
$5,687 in reported general payments places this provider in the 90th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 112 | $91,195 |
| OzempicSemaglutide | 96 | $87,213 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 78 | $64,946 |
| MounjaroTirzepatide | 43 | $47,923 |
| XareltoRivaroxaban | 46 | $33,075 |
| JardianceEmpagliflozin | 36 | $27,897 |
| TrulicityDulaglutide | 12 | $25,007 |
| JanuviaSitagliptin Phosphate | 25 | $20,916 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $7,717 |
| EntrestoSacubitril/Valsartan | 11 | $7,117 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $6,502 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $5,590 |
| Novolog FlexpenInsulin Aspart | 16 | $4,807 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $4,642 |
| Duloxetine Hcl | 165 | $3,827 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $250 | $91,195112 claims |
| Novo NordiskOzempic | $409 | $87,21396 claims |
| Lilly USA, LLCMounjaro, Trulicity | $253 | $72,92955 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $348 | $71,44992 claims |
| Johnson & JohnsonXarelto | $186 | $33,07546 claims |
| Boehringer IngelheimJardiance | $176 | $27,89736 claims |
| MerckJanuvia | $253 | $20,91625 claims |
| NovartisEntresto | $225 | $7,11711 claims |
| AstraZenecaSymbicort | $345 | $4,64213 claims |
| AbbVieSynthroid | $969 | $2,15235 claims |
| Almatica Pharma LLCSertraline Hcl | $11 | $1,334172 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,248 family providers in South Carolina.
Other family in Landrum
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.